Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TTC3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | ZNF461 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | NPIPA1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | USP11 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | ZNF136 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | PELI2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
mRNA | SYP | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |